nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemifloxacin—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.00267	0.00267	CcSEcCtD
Gemifloxacin—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.00266	0.00266	CcSEcCtD
Gemifloxacin—Hyperglycaemia—Prednisone—ankylosing spondylitis	0.00263	0.00263	CcSEcCtD
Gemifloxacin—Visual impairment—Dexamethasone—ankylosing spondylitis	0.00259	0.00259	CcSEcCtD
Gemifloxacin—Visual impairment—Betamethasone—ankylosing spondylitis	0.00259	0.00259	CcSEcCtD
Gemifloxacin—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.00259	0.00259	CcSEcCtD
Gemifloxacin—Neuropathy peripheral—Prednisone—ankylosing spondylitis	0.00255	0.00255	CcSEcCtD
Gemifloxacin—Breast disorder—Methotrexate—ankylosing spondylitis	0.00255	0.00255	CcSEcCtD
Gemifloxacin—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Gemifloxacin—Vertigo—Prednisolone—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Gemifloxacin—Syncope—Prednisolone—ankylosing spondylitis	0.00251	0.00251	CcSEcCtD
Gemifloxacin—Eye disorder—Dexamethasone—ankylosing spondylitis	0.00251	0.00251	CcSEcCtD
Gemifloxacin—Eye disorder—Betamethasone—ankylosing spondylitis	0.00251	0.00251	CcSEcCtD
Gemifloxacin—Back pain—Triamcinolone—ankylosing spondylitis	0.00249	0.00249	CcSEcCtD
Gemifloxacin—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.00246	0.00246	CcSEcCtD
Gemifloxacin—Angiopathy—Betamethasone—ankylosing spondylitis	0.00243	0.00243	CcSEcCtD
Gemifloxacin—Angiopathy—Dexamethasone—ankylosing spondylitis	0.00243	0.00243	CcSEcCtD
Gemifloxacin—Eosinophilia—Methotrexate—ankylosing spondylitis	0.00242	0.00242	CcSEcCtD
Gemifloxacin—Pancreatitis—Methotrexate—ankylosing spondylitis	0.00239	0.00239	CcSEcCtD
Gemifloxacin—Haemoglobin—Prednisone—ankylosing spondylitis	0.00235	0.00235	CcSEcCtD
Gemifloxacin—Haemorrhage—Prednisone—ankylosing spondylitis	0.00234	0.00234	CcSEcCtD
Gemifloxacin—Vertigo—Triamcinolone—ankylosing spondylitis	0.00231	0.00231	CcSEcCtD
Gemifloxacin—Syncope—Triamcinolone—ankylosing spondylitis	0.00231	0.00231	CcSEcCtD
Gemifloxacin—Vertigo—Methylprednisolone—ankylosing spondylitis	0.00231	0.00231	CcSEcCtD
Gemifloxacin—Syncope—Methylprednisolone—ankylosing spondylitis	0.0023	0.0023	CcSEcCtD
Gemifloxacin—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.0023	0.0023	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Gemifloxacin—Oedema—Prednisolone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Gemifloxacin—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.00226	0.00226	CcSEcCtD
Gemifloxacin—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00226	0.00226	CcSEcCtD
Gemifloxacin—Shock—Prednisolone—ankylosing spondylitis	0.00225	0.00225	CcSEcCtD
Gemifloxacin—Tachycardia—Prednisolone—ankylosing spondylitis	0.00223	0.00223	CcSEcCtD
Gemifloxacin—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.00223	0.00223	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00221	0.00221	CcSEcCtD
Gemifloxacin—Myalgia—Triamcinolone—ankylosing spondylitis	0.00219	0.00219	CcSEcCtD
Gemifloxacin—Pneumonia—Methotrexate—ankylosing spondylitis	0.00219	0.00219	CcSEcCtD
Gemifloxacin—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.00219	0.00219	CcSEcCtD
Gemifloxacin—Myalgia—Methylprednisolone—ankylosing spondylitis	0.00219	0.00219	CcSEcCtD
Gemifloxacin—Eye disorder—Prednisone—ankylosing spondylitis	0.00218	0.00218	CcSEcCtD
Gemifloxacin—Infestation NOS—Methotrexate—ankylosing spondylitis	0.00218	0.00218	CcSEcCtD
Gemifloxacin—Infestation—Methotrexate—ankylosing spondylitis	0.00218	0.00218	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00217	0.00217	CcSEcCtD
Gemifloxacin—Flushing—Prednisone—ankylosing spondylitis	0.00217	0.00217	CcSEcCtD
Gemifloxacin—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00214	0.00214	CcSEcCtD
Gemifloxacin—Renal failure—Methotrexate—ankylosing spondylitis	0.00214	0.00214	CcSEcCtD
Gemifloxacin—Stomatitis—Methotrexate—ankylosing spondylitis	0.00212	0.00212	CcSEcCtD
Gemifloxacin—Angiopathy—Prednisone—ankylosing spondylitis	0.00212	0.00212	CcSEcCtD
Gemifloxacin—Immune system disorder—Prednisone—ankylosing spondylitis	0.00211	0.00211	CcSEcCtD
Gemifloxacin—Oedema—Triamcinolone—ankylosing spondylitis	0.0021	0.0021	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.0021	0.0021	CcSEcCtD
Gemifloxacin—Vertigo—Betamethasone—ankylosing spondylitis	0.0021	0.0021	CcSEcCtD
Gemifloxacin—Vertigo—Dexamethasone—ankylosing spondylitis	0.0021	0.0021	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.0021	0.0021	CcSEcCtD
Gemifloxacin—Syncope—Betamethasone—ankylosing spondylitis	0.0021	0.0021	CcSEcCtD
Gemifloxacin—Syncope—Dexamethasone—ankylosing spondylitis	0.0021	0.0021	CcSEcCtD
Gemifloxacin—Haematuria—Methotrexate—ankylosing spondylitis	0.00207	0.00207	CcSEcCtD
Gemifloxacin—Shock—Triamcinolone—ankylosing spondylitis	0.00207	0.00207	CcSEcCtD
Gemifloxacin—Insomnia—Prednisolone—ankylosing spondylitis	0.00207	0.00207	CcSEcCtD
Gemifloxacin—Shock—Methylprednisolone—ankylosing spondylitis	0.00206	0.00206	CcSEcCtD
Gemifloxacin—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.00206	0.00206	CcSEcCtD
Gemifloxacin—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00206	0.00206	CcSEcCtD
Gemifloxacin—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Gemifloxacin—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Gemifloxacin—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Gemifloxacin—Mental disorder—Prednisone—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Gemifloxacin—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Gemifloxacin—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Gemifloxacin—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Gemifloxacin—Myalgia—Dexamethasone—ankylosing spondylitis	0.00199	0.00199	CcSEcCtD
Gemifloxacin—Myalgia—Betamethasone—ankylosing spondylitis	0.00199	0.00199	CcSEcCtD
Gemifloxacin—Haemoglobin—Methotrexate—ankylosing spondylitis	0.00196	0.00196	CcSEcCtD
Gemifloxacin—Pain—Prednisolone—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Gemifloxacin—Haemorrhage—Methotrexate—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Gemifloxacin—Pharyngitis—Methotrexate—ankylosing spondylitis	0.00194	0.00194	CcSEcCtD
Gemifloxacin—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.00193	0.00193	CcSEcCtD
Gemifloxacin—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Gemifloxacin—Oedema—Dexamethasone—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Gemifloxacin—Oedema—Betamethasone—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Gemifloxacin—Insomnia—Triamcinolone—ankylosing spondylitis	0.0019	0.0019	CcSEcCtD
Gemifloxacin—Insomnia—Methylprednisolone—ankylosing spondylitis	0.0019	0.0019	CcSEcCtD
Gemifloxacin—Visual impairment—Methotrexate—ankylosing spondylitis	0.00188	0.00188	CcSEcCtD
Gemifloxacin—Anaemia—Prednisone—ankylosing spondylitis	0.00188	0.00188	CcSEcCtD
Gemifloxacin—Shock—Betamethasone—ankylosing spondylitis	0.00188	0.00188	CcSEcCtD
Gemifloxacin—Shock—Dexamethasone—ankylosing spondylitis	0.00188	0.00188	CcSEcCtD
Gemifloxacin—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00187	0.00187	CcSEcCtD
Gemifloxacin—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00187	0.00187	CcSEcCtD
Gemifloxacin—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00187	0.00187	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00187	0.00187	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00187	0.00187	CcSEcCtD
Gemifloxacin—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00186	0.00186	CcSEcCtD
Gemifloxacin—Tachycardia—Betamethasone—ankylosing spondylitis	0.00186	0.00186	CcSEcCtD
Gemifloxacin—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Gemifloxacin—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Gemifloxacin—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00184	0.00184	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00184	0.00184	CcSEcCtD
Gemifloxacin—Vertigo—Prednisone—ankylosing spondylitis	0.00183	0.00183	CcSEcCtD
Gemifloxacin—Eye disorder—Methotrexate—ankylosing spondylitis	0.00183	0.00183	CcSEcCtD
Gemifloxacin—Syncope—Prednisone—ankylosing spondylitis	0.00182	0.00182	CcSEcCtD
Gemifloxacin—Anorexia—Betamethasone—ankylosing spondylitis	0.00182	0.00182	CcSEcCtD
Gemifloxacin—Anorexia—Dexamethasone—ankylosing spondylitis	0.00182	0.00182	CcSEcCtD
Gemifloxacin—Urticaria—Prednisolone—ankylosing spondylitis	0.00182	0.00182	CcSEcCtD
Gemifloxacin—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.00181	0.00181	CcSEcCtD
Gemifloxacin—Fatigue—Triamcinolone—ankylosing spondylitis	0.00181	0.00181	CcSEcCtD
Gemifloxacin—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00181	0.00181	CcSEcCtD
Gemifloxacin—Pain—Triamcinolone—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Gemifloxacin—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Gemifloxacin—Angiopathy—Methotrexate—ankylosing spondylitis	0.00177	0.00177	CcSEcCtD
Gemifloxacin—Immune system disorder—Methotrexate—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Gemifloxacin—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Gemifloxacin—Arthralgia—Prednisone—ankylosing spondylitis	0.00173	0.00173	CcSEcCtD
Gemifloxacin—Myalgia—Prednisone—ankylosing spondylitis	0.00173	0.00173	CcSEcCtD
Gemifloxacin—Insomnia—Dexamethasone—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Gemifloxacin—Insomnia—Betamethasone—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00171	0.00171	CcSEcCtD
Gemifloxacin—Mental disorder—Methotrexate—ankylosing spondylitis	0.00171	0.00171	CcSEcCtD
Gemifloxacin—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Gemifloxacin—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Gemifloxacin—Urticaria—Triamcinolone—ankylosing spondylitis	0.00167	0.00167	CcSEcCtD
Gemifloxacin—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00167	0.00167	CcSEcCtD
Gemifloxacin—Dysgeusia—Methotrexate—ankylosing spondylitis	0.00167	0.00167	CcSEcCtD
Gemifloxacin—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00166	0.00166	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.00166	0.00166	CcSEcCtD
Gemifloxacin—Oedema—Prednisone—ankylosing spondylitis	0.00166	0.00166	CcSEcCtD
Gemifloxacin—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00166	0.00166	CcSEcCtD
Gemifloxacin—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00166	0.00166	CcSEcCtD
Gemifloxacin—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00166	0.00166	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00165	0.00165	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00165	0.00165	CcSEcCtD
Gemifloxacin—Back pain—Methotrexate—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Gemifloxacin—Fatigue—Betamethasone—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Gemifloxacin—Fatigue—Dexamethasone—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Gemifloxacin—Shock—Prednisone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Gemifloxacin—Pain—Dexamethasone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Gemifloxacin—Pain—Betamethasone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Gemifloxacin—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Gemifloxacin—Tachycardia—Prednisone—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Gemifloxacin—Skin disorder—Prednisone—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Gemifloxacin—Anorexia—Prednisone—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Gemifloxacin—Anaemia—Methotrexate—ankylosing spondylitis	0.00157	0.00157	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Gemifloxacin—Vertigo—Methotrexate—ankylosing spondylitis	0.00153	0.00153	CcSEcCtD
Gemifloxacin—Leukopenia—Methotrexate—ankylosing spondylitis	0.00152	0.00152	CcSEcCtD
Gemifloxacin—Urticaria—Dexamethasone—ankylosing spondylitis	0.00151	0.00151	CcSEcCtD
Gemifloxacin—Urticaria—Betamethasone—ankylosing spondylitis	0.00151	0.00151	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00151	0.00151	CcSEcCtD
Gemifloxacin—Dizziness—Prednisolone—ankylosing spondylitis	0.00151	0.00151	CcSEcCtD
Gemifloxacin—Asthenia—Triamcinolone—ankylosing spondylitis	0.00151	0.00151	CcSEcCtD
Gemifloxacin—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00151	0.00151	CcSEcCtD
Gemifloxacin—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00151	0.00151	CcSEcCtD
Gemifloxacin—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00151	0.00151	CcSEcCtD
Gemifloxacin—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00151	0.00151	CcSEcCtD
Gemifloxacin—Asthenia—Methylprednisolone—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Gemifloxacin—Insomnia—Prednisone—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Gemifloxacin—Pruritus—Triamcinolone—ankylosing spondylitis	0.00149	0.00149	CcSEcCtD
Gemifloxacin—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00148	0.00148	CcSEcCtD
Gemifloxacin—Dyspepsia—Prednisone—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Gemifloxacin—Arthralgia—Methotrexate—ankylosing spondylitis	0.00145	0.00145	CcSEcCtD
Gemifloxacin—Myalgia—Methotrexate—ankylosing spondylitis	0.00145	0.00145	CcSEcCtD
Gemifloxacin—Decreased appetite—Prednisone—ankylosing spondylitis	0.00144	0.00144	CcSEcCtD
Gemifloxacin—Rash—Prednisolone—ankylosing spondylitis	0.00144	0.00144	CcSEcCtD
Gemifloxacin—Dermatitis—Prednisolone—ankylosing spondylitis	0.00144	0.00144	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00144	0.00144	CcSEcCtD
Gemifloxacin—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Gemifloxacin—Fatigue—Prednisone—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Gemifloxacin—Headache—Prednisolone—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Gemifloxacin—Constipation—Prednisone—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Gemifloxacin—Dizziness—Triamcinolone—ankylosing spondylitis	0.00139	0.00139	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00139	0.00139	CcSEcCtD
Gemifloxacin—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00139	0.00139	CcSEcCtD
Gemifloxacin—Asthenia—Betamethasone—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Gemifloxacin—Asthenia—Dexamethasone—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Gemifloxacin—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Gemifloxacin—Nausea—Prednisolone—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Gemifloxacin—Pruritus—Dexamethasone—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Gemifloxacin—Pruritus—Betamethasone—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Gemifloxacin—Skin disorder—Methotrexate—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00134	0.00134	CcSEcCtD
Gemifloxacin—Vomiting—Triamcinolone—ankylosing spondylitis	0.00134	0.00134	CcSEcCtD
Gemifloxacin—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00133	0.00133	CcSEcCtD
Gemifloxacin—Rash—Triamcinolone—ankylosing spondylitis	0.00132	0.00132	CcSEcCtD
Gemifloxacin—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00132	0.00132	CcSEcCtD
Gemifloxacin—Anorexia—Methotrexate—ankylosing spondylitis	0.00132	0.00132	CcSEcCtD
Gemifloxacin—Rash—Methylprednisolone—ankylosing spondylitis	0.00132	0.00132	CcSEcCtD
Gemifloxacin—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00132	0.00132	CcSEcCtD
Gemifloxacin—Urticaria—Prednisone—ankylosing spondylitis	0.00132	0.00132	CcSEcCtD
Gemifloxacin—Headache—Triamcinolone—ankylosing spondylitis	0.00132	0.00132	CcSEcCtD
Gemifloxacin—Headache—Methylprednisolone—ankylosing spondylitis	0.00131	0.00131	CcSEcCtD
Gemifloxacin—Abdominal pain—Prednisone—ankylosing spondylitis	0.00131	0.00131	CcSEcCtD
Gemifloxacin—Body temperature increased—Prednisone—ankylosing spondylitis	0.00131	0.00131	CcSEcCtD
Gemifloxacin—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Gemifloxacin—Diarrhoea—Betamethasone—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.00126	0.00126	CcSEcCtD
Gemifloxacin—Dizziness—Dexamethasone—ankylosing spondylitis	0.00126	0.00126	CcSEcCtD
Gemifloxacin—Dizziness—Betamethasone—ankylosing spondylitis	0.00126	0.00126	CcSEcCtD
Gemifloxacin—Insomnia—Methotrexate—ankylosing spondylitis	0.00126	0.00126	CcSEcCtD
Gemifloxacin—Nausea—Triamcinolone—ankylosing spondylitis	0.00125	0.00125	CcSEcCtD
Gemifloxacin—Nausea—Methylprednisolone—ankylosing spondylitis	0.00125	0.00125	CcSEcCtD
Gemifloxacin—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00124	0.00124	CcSEcCtD
Gemifloxacin—Somnolence—Methotrexate—ankylosing spondylitis	0.00123	0.00123	CcSEcCtD
Gemifloxacin—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00122	0.00122	CcSEcCtD
Gemifloxacin—Vomiting—Dexamethasone—ankylosing spondylitis	0.00121	0.00121	CcSEcCtD
Gemifloxacin—Vomiting—Betamethasone—ankylosing spondylitis	0.00121	0.00121	CcSEcCtD
Gemifloxacin—Decreased appetite—Methotrexate—ankylosing spondylitis	0.00121	0.00121	CcSEcCtD
Gemifloxacin—Rash—Betamethasone—ankylosing spondylitis	0.0012	0.0012	CcSEcCtD
Gemifloxacin—Rash—Dexamethasone—ankylosing spondylitis	0.0012	0.0012	CcSEcCtD
Gemifloxacin—Dermatitis—Dexamethasone—ankylosing spondylitis	0.0012	0.0012	CcSEcCtD
Gemifloxacin—Dermatitis—Betamethasone—ankylosing spondylitis	0.0012	0.0012	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.0012	0.0012	CcSEcCtD
Gemifloxacin—Fatigue—Methotrexate—ankylosing spondylitis	0.0012	0.0012	CcSEcCtD
Gemifloxacin—Headache—Dexamethasone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Gemifloxacin—Headache—Betamethasone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Gemifloxacin—Asthenia—Prednisone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Gemifloxacin—Pain—Methotrexate—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Gemifloxacin—Pruritus—Prednisone—ankylosing spondylitis	0.00117	0.00117	CcSEcCtD
Gemifloxacin—Diarrhoea—Prednisone—ankylosing spondylitis	0.00114	0.00114	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00113	0.00113	CcSEcCtD
Gemifloxacin—Nausea—Dexamethasone—ankylosing spondylitis	0.00113	0.00113	CcSEcCtD
Gemifloxacin—Nausea—Betamethasone—ankylosing spondylitis	0.00113	0.00113	CcSEcCtD
Gemifloxacin—Urticaria—Methotrexate—ankylosing spondylitis	0.0011	0.0011	CcSEcCtD
Gemifloxacin—Dizziness—Prednisone—ankylosing spondylitis	0.0011	0.0011	CcSEcCtD
Gemifloxacin—Abdominal pain—Methotrexate—ankylosing spondylitis	0.0011	0.0011	CcSEcCtD
Gemifloxacin—Body temperature increased—Methotrexate—ankylosing spondylitis	0.0011	0.0011	CcSEcCtD
Gemifloxacin—Vomiting—Prednisone—ankylosing spondylitis	0.00106	0.00106	CcSEcCtD
Gemifloxacin—Rash—Prednisone—ankylosing spondylitis	0.00105	0.00105	CcSEcCtD
Gemifloxacin—Dermatitis—Prednisone—ankylosing spondylitis	0.00105	0.00105	CcSEcCtD
Gemifloxacin—Headache—Prednisone—ankylosing spondylitis	0.00104	0.00104	CcSEcCtD
Gemifloxacin—Asthenia—Methotrexate—ankylosing spondylitis	0.000996	0.000996	CcSEcCtD
Gemifloxacin—Nausea—Prednisone—ankylosing spondylitis	0.000986	0.000986	CcSEcCtD
Gemifloxacin—Pruritus—Methotrexate—ankylosing spondylitis	0.000982	0.000982	CcSEcCtD
Gemifloxacin—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000949	0.000949	CcSEcCtD
Gemifloxacin—Dizziness—Methotrexate—ankylosing spondylitis	0.000918	0.000918	CcSEcCtD
Gemifloxacin—Vomiting—Methotrexate—ankylosing spondylitis	0.000882	0.000882	CcSEcCtD
Gemifloxacin—Rash—Methotrexate—ankylosing spondylitis	0.000875	0.000875	CcSEcCtD
Gemifloxacin—Dermatitis—Methotrexate—ankylosing spondylitis	0.000874	0.000874	CcSEcCtD
Gemifloxacin—Headache—Methotrexate—ankylosing spondylitis	0.000869	0.000869	CcSEcCtD
Gemifloxacin—Nausea—Methotrexate—ankylosing spondylitis	0.000824	0.000824	CcSEcCtD
